Intraosseous Infusion Devices Market 2023-2030: Comprehensive Industry Analysis and Growth Projections Intraosseous infusion devices are medical devices used to administer fluids and medications directly into the bone marrow when intravenous access is not feasible. The global market for intraosseous infusion devices was valued at USD 829.5 million in 2021 and is expected to grow at a CAGR of 5.1 percent during the forecast period. The market growth is driven by factors such as the increasing prevalence of chronic conditions like traumatic injuries, cardiovascular illnesses, obesity, and serious burns that require hospitalization, as well as the rise in emergency medical cases. Access Full Report: https://www.fairfieldmarketresearch.com/report/intraosseous-
infusion-devices-market
Sedentary lifestyles have also contributed to the market's expansion as they lead to various health conditions, including diabetes, urological disorders, cardiovascular diseases, and chronic obstructive pulmonary disease. The success rate of intraosseous devices, which is over 97%, has further propelled the market's growth. The procedure of intraosseous infusion is recommended when peripheral venous access fails and during cardiac resuscitation, which has driven the market's expansion. Additionally, the increasing number of traumatic surgeries performed in various hospital settings and the prevalence of cardiovascular disorders are expected to boost the market for intraosseous infusion devices in the coming years. The COVID-19 pandemic has also had a positive impact on the market, as the need for emergency medical services has increased during the epidemic. I.O. devices have been crucial in providing quick infusion of fluids and medications in critical clinical situations such as serious burns, accidents, or trauma where intravenous access is not available. While the market shows promising growth, there are concerns about the lack of evidence supporting the use of intraosseous devices compared to medications, which calls for more